FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Temozolomide (TEMODAR) Capsules
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

Merck Sharp & Dohme Corp. (New 01/23/2020)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
5 mg child-resistent sachets, 5 count (NDC 0085-3004-03) 01/23/2020 To be discontinued on or near March 2020.
5 mg child-resistent sachets, 14 count (NDC 0085-3004-04) 01/23/2020 To be discontinued on or near March 2020.
20 mg child-resistent sachets, 5 count (NDC 0085-1519-03) 01/23/2020 To be discontinued on or near Jun 2020.
20 mg child-resistent sachets, 14 count (NDC 0085-1519-04) 01/23/2020 Discontinued in 2018.
140 mg child-resistent sachets, 5 count (NDC 0085-1425-03) 01/23/2020 To be discontinued on or near Aug 2020.
180 mg child-resistent sacehts, 14 count (NDC 0085-1430-04) 01/23/2020 Discontinued in 2018.
5 mg, 5 capsules (NDC 0781-2691-75) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
5 mg, 14 capsules (NDC 0781-2691-44) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
20 mg, 5 capsules (NDC 0781-2692-75) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
20 mg, 14 capsules (NDC 0781-2692-44) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
100 mg, 5 capsules (NDC 0781-2693-75) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
100 mg, 14 capsules (MDC 0781-2693-44) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
140 mg, 5 capsules (NDC 0781-2694-75) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
140 mg, 14 capsules (NDC 0781-2694-44) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
180 mg, 5 capsules (NDC 0781-2695-75) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
180 mg, 14 capsules (NDC 0781-2695-44) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.
250 mg, 5 capsules (NDC 0781-2696-75) 01/23/2020 Authorized generic distributed by Sandoz 609-627-8500. All authorized generic presentations will be discontinued as of 31 December 2019.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English